ab13493 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab13493 は 7 報の論文で使用されています。

  • Bandyopadhyay C  et al. CIB1 synergizes with EphrinA2 to regulate Kaposi's sarcoma-associated herpesvirus macropinocytic entry in human microvascular dermal endothelial cells. PLoS Pathog 10:e1003941 (2014). ICC/IF ; Human . PubMed: 24550731
  • Korhonen JT  et al. Flotillin-1 (Reggie-2) contributes to Chlamydia pneumoniae growth and is associated with bacterial inclusion. Infect Immun 80:1072-8 (2012). ICC/IF ; Human . PubMed: 22215737
  • Chakraborty S  et al. c-Cbl-mediated selective virus-receptor translocations into lipid rafts regulate productive Kaposi's sarcoma-associated herpesvirus infection in endothelial cells. J Virol 85:12410-30 (2011). PubMed: 21937638
  • He B  et al. The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88. Nat Immunol 11:836-45 (2010). ICC/IF ; Human . PubMed: 20676093
  • Masilamani M  et al. Uncommon endocytic and trafficking pathway of the natural killer cell CD94/NKG2A inhibitory receptor. Traffic 9:1019-34 (2008). ICC/IF ; Human . PubMed: 18363778
  • Leclerc E  et al. S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains. J Biol Chem 282:31317-31 (2007). WB ; Human . PubMed: 17726019
  • Dolganiuc A  et al. Acute ethanol treatment modulates Toll-like receptor-4 association with lipid rafts. Alcohol Clin Exp Res 30:76-85 (2006). PubMed: 16433734

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"